M17-B15
M17-B15 is an androgen receptor dimerization inhibitor with an IC50 of 30 nM. M17-B15 effectively disrupts AR self-association, thereby suppressing AR signaling. M17-B15 exhibits extraordinary anti- prostate cancer (PCa) efficacy in vitro and in mouse xenograft tumor models.M17-B15 can be used for the study of prostate cancer[1].
Product Specifications
CAS Number
[708291-86-5]
UNSPSC
12352005
Target
Androgen Receptor
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
O=C(C1=C(C)OC(C2=CC(C(F)(F)F)=CC=C2)=C1)NC3=NC(CC(C)=O)=NS3
Molecular Formula
C18H14F3N3O3S
Molecular Weight
409.38
References & Citations
[1]Fu W, et al. Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer. ACS Cent Sci. 2023 Mar 8;9 (4) :675-684.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1133301-01 0.02 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Membrane-bound lytic murein transglycosylase F (mltF)
Ask
View Details 
MBS1133301-02 0.02 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Membrane-bound lytic murein transglycosylase F (mltF)
Ask
View Details MBS1133301-03 0.1 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Membrane-bound lytic murein transglycosylase F (mltF)
Ask
View Details 
MBS1133301-04 0.1 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Membrane-bound lytic murein transglycosylase F (mltF)
Ask
View Details 
MBS1133301-05 0.02 mg (Baculovirus)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Membrane-bound lytic murein transglycosylase F (mltF)
Ask
View Details MBS1133301-06 0.02 mg (Mammalian-Cell)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Membrane-bound lytic murein transglycosylase F (mltF)
Ask
View Details